InvestorsHub Logo

Borel Fields

05/05/20 11:17 AM

#74778 RE: hitekmastr #74726

Dr. Otto Yang of UCLA Health, who has treated 23 EIND patients and is the PI for both leronlimab RCTs there, is a panelist at a UCLA Clinical Research talk at 3:00 pdt Wednesday. Preview of his input to the outcomes paper?